Key Events This Week
4 May: Week opens at Rs.480.15
6 May: Stock gains 2.01% amid rising volumes
7 May: Intraday high of Rs.526.90 with 10.65% close gain
8 May: Technical momentum shifts amid mixed signals, closes at Rs.544.90 (+0.98%)

Rossari Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-08 08:05:11Rossari Biotech Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a robust intraday gain of 10.01%, the company’s overall technical profile presents a blend of bullish and bearish signals, prompting a downgrade in its Mojo Grade from Hold to Sell as of 8 December 2025.
Read full news article
Rossari Biotech Ltd Surges 10.87% to Day's High of Rs 526.9 — Outperforms Sector by 7.16 Percentage Points
2026-05-07 10:01:09The Sensex edged up a mere 0.03% on 7 May 2026, while Rossari Biotech Ltd surged 10.87%, marking a standout session in the Specialty Chemicals sector with a 7.16 percentage-point outperformance. This sharp intraday gain rewrites the short-term narrative for the stock, which has been on a five-day winning streak, raising questions about the sustainability of this momentum.
Read full news article
Rossari Biotech Ltd is Rated Sell
2026-05-06 10:10:40Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleRossari Biotech’s Volatile Week: -7.25% Amid Technical Setbacks and Intraday Rebound
2026-05-02 12:01:40
Key Events This Week
27 Apr: Stock opens at Rs.506.15, declines amid broader market gains
28 Apr: Intraday low hit at Rs.464.5 amid heavy price pressure
29 Apr: Bearish momentum confirmed with 7.51% drop to Rs.468.15
30 Apr: Intraday high of Rs.508.85 with 9.18% surge, closing at Rs.478.75

Rossari Biotech Ltd Surges 9.18% to Day's High of Rs 508.85 — Outperforms Sector by 7.53 Percentage Points
2026-04-30 14:01:02The Sensex declined by 0.38% on 30 Apr 2026, while Rossari Biotech Ltd surged 9.18%, outperforming its Specialty Chemicals sector by 7.53 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read full news article
Rossari Biotech Ltd Faces Technical Momentum Shift Amid Bearish Trends
2026-04-30 08:03:25Rossari Biotech Ltd, a specialty chemicals company, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid a challenging market backdrop.
Read full news article
Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downturn
2026-04-29 08:03:52Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a marked shift in price momentum and technical indicators, signalling a deteriorating outlook. The stock’s recent 7.51% decline to ₹468.15, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects growing bearish sentiment among investors and analysts alike.
Read full news articleAre Rossari Biotech Ltd latest results good or bad?
2026-04-28 19:15:25Rossari Biotech Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported consolidated net sales of ₹684.86 crores, reflecting a sequential growth of 17.74% and an 18.17% increase year-on-year. This performance indicates resilience in revenue generation, although it represents a deceleration compared to the company's historical growth trajectory, which has averaged a five-year CAGR of 28.63%. On the profit side, consolidated net profit reached ₹45.97 crores, marking a significant sequential increase of 40.28% and a year-on-year growth of 33.48%. However, this profit surge was significantly bolstered by exceptional other income of ₹19.07 crores, raising questions about the sustainability of such earnings quality in future periods. Despite these positive headline figures, the operating margin (excluding other income) declined to 11.28%, down from 11.84% in the previous quart...
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
04-May-2026 | Source : BSEIntimation of Transcript of Q4 FY 26 for the Earnings Conference Call held on April 28 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
28-Apr-2026 | Source : BSERossari Biotech Limited informed the Exchange regarding Press Release dated April 27 2026 titled Rossari Biotech announces Q4 FY 26 results.
Announcement under Regulation 30 (LODR)-Newspaper Publication
28-Apr-2026 | Source : BSENewspaper Publication of extract of Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31 2026.
Corporate Actions
No Upcoming Board Meetings
Rossari Biotech Ltd has declared 25% dividend, ex-date: 16 Aug 24
No Splits history available
No Bonus history available
No Rights history available






